<DOC>
	<DOCNO>NCT00440622</DOCNO>
	<brief_summary>The optimal treatment pretreated patient metastatic breast cancer establish . Gemcitabine capecitabine two active agent set . For woman Her-2 positive breast cancer , combination either gemcitabine capecitabine ( Xeloda ) plus Herceptin prove active well tolerate .</brief_summary>
	<brief_title>Study Gemcitabine Herceptin Versus Xeloda Herceptin HER-2 ( + ) Metastatic Breast Cancer Patients</brief_title>
	<detailed_description>This trial compare efficacy combination gemcitabine plus Herceptin versus capecitabine ( Xeloda ) plus Herceptin pretreated patient metastatic HER-2 positive breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Informed consent Histologically confirm metastatic breast adenocarcinoma ( stage IV ) without prior chemotherapy receive HER2 overexpression 2+ 3+ use IHC FISH + Measurable disease At least one prior chemotherapy regimen Not prior irradiation field No patient brain metastatic disease irradiate uncontrolled brain metastatic disease irradiation No 25 % myeloproductive bone marrow irradiate . More 4 week since prior radiotherapy recover Age 18 75 year old Performance status ( WHO ) 02 Life expectancy 12 week Absolute neutrophil count &gt; 1500/mm^3 , platelet count &gt; 100000/mm^3 , hemoglobin &gt; 9 gr/mm^3 ) Adequate liver ( bilirubin &lt; 2 mg/dL , SGOT/SGPT &lt; 2 time upper limit normal , ALP &lt; 3 time upper limit normal , creatinine &lt; 1.5 upper limit normal Adequate cardiac function ( LVEF &gt; 50 % ) Pregnant nursing Positive pregnancy test Concurrent agent ketoconazole , macrolide antibiotic , zidovudine may induce P450 cytochrome Motor sensory neuropathy &gt; grade 1 accord NCIC toxicity criterion History allergic reaction attribute docetaxel Psychiatric illness social situation would preclude study compliance Other concurrent uncontrolled illness Other invasive malignancy within past 5 year except cure basal cell skin carcinoma cervical carcinoma situ</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Metastatic Breast cancer</keyword>
	<keyword>Her-2 expression</keyword>
	<keyword>Gemcitabine</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Herceptin</keyword>
</DOC>